Diphenylhydantoin‐induced Gingival Hyperplasia: Its Response to Changes in Drug Dosage
- 1 August 1975
- journal article
- Published by Wiley in Developmental Medicine and Child Neurology
- Vol. 17 (4) , 421-424
- https://doi.org/10.1111/j.1469-8749.1975.tb03492.x
Abstract
Changes in gingival hyperplasia were studied in 48 patients treated for epilepsy with diphenylhydantoin (DPH) over a two-year period. During this time changes in the dose of DPH were made in some patients in order to increase control of seizures or decrease side-effects: in 27 patients the dose was increased, in nine it was decreased and in 12 the dose remained unchanged. It was found that the severity of gingival hyperplasia varied directly with both the dose and serum level of the drug.Keywords
This publication has 7 references indexed in Scilit:
- GINGIVAL HYPERPLASIA DURING DILANTIN‐THERAPY; A SURVEY OF 312 PATIENTS*Journal of Public Health Dentistry, 1973
- Diphenylhydantoin‐induced Gingival Hyperplasia: its Relationship to Dose and Serum LevelDevelopmental Medicine and Child Neurology, 1973
- Gingival Hyperplasia and DiphenylhydantoinThe Journal of Periodontology, 1972
- The rapid quantitative determination of diphenylhydantoin in plasma, serum, and whole blood of patients with epilepsyClinica Chimica Acta; International Journal of Clinical Chemistry, 1971
- BIOCHEMICAL AND GENETIC FACTORS REGULATING DILANTIN METABOLISM IN MAN*Annals of the New York Academy of Sciences, 1971
- Incidence of gingival hyperplasia associated with Dilantin therapy in a hospital populationThe Journal of the American Dental Association, 1965
- Speculations Regarding the Nature of Gingival Hyperplasia Due to Diphenylhydantoin‐sodium.Acta Medica Scandinavica, 1955